PEPG · PepGen Inc
United States · RS rating 67 · As of 2026-11-03
| Price | 2.46 USD |
|---|---|
| 1-day change | +4.7% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 69 / 91 / 23 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 33 / 18 / 60 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +48.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +65.7% |
| Market cap (USD) | $109.9M |